Karius

About:

Karius delivers genomic insights into infectious diseases, helping clinicians make critical, life-saving treatment decisions.

Website: https://kariusdx.com

Twitter/X: kariusdx

Top Investors: Khosla Ventures, General Catalyst, Lightspeed Venture Partners, Tencent, Seventure Partners

Description:

Karius is a life sciences company focused on generating genomic insights for infectious diseases with a liquid biopsy for infectious diseases. The Karius Test that helps clinicians make rapid, treatment decisions. By mapping each patient’s microbial landscape from a single blood draw, Karius moves closer to a vision of a world where infectious disease is no longer a major threat to human health. The Karius laboratory is CLIA-certified and CAP-accredited to perform high-complexity clinical laboratory testing.

Total Funding Amount:

$354M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Redwood City, California, United States

Founded Date:

2014-01-01

Contact Email:

media(AT)kariusdx.com

Hub Tags:

Emerging Unicorn

Founders:

Mickey Kertesz, Steve Quake, Tim Blauwkamp

Number of Employees:

101-250

Last Funding Date:

2024-05-02

IPO Status:

Private

© 2025 bioDAO.ai